Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa

ClinicalTrials.gov ID: NCT04019041

Public ClinicalTrials.gov record NCT04019041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 1:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients With Moderate to Severe Hidradenitis Suppurativa

Study identification

NCT ID
NCT04019041
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
153 participants

Conditions and interventions

Interventions

  • bermekimab Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2019
Primary completion
May 18, 2020
Completion
Nov 16, 2020
Last update posted
Jul 26, 2023

2019 – 2020

United States locations

U.S. sites
33
U.S. states
13
U.S. cities
28
Facility City State ZIP Site status
Desert Sky Gilbert Arizona 85295
Marvel Clinical Research Huntington Beach California 92647
University of Southern California Los Angeles California 90033
Dermatology Research Associates Los Angeles California 90045
Syrentis Clinical Research Santa Ana California 92705
Wolverine Clinical Trials Santa Ana California 92705
Visionary Investigators Network Aventura Florida 33180
Florida Academic Dermatology Centers Coral Gables Florida 33134
Doral Medical Research Doral Florida 33166
Floridian Research Institute Miami Florida 33145
Florida International Medical Research Miami Florida 33155
P&S Research, LLC Miami Florida 33175
Accel Clinical Research Orlando Florida 32819
Physica Clinical Research Sebastian Florida 32958
Avita Clinical Research Tampa Florida 33613
Forcare Clinical Research, Inc. Tampa Florida 33613
Integrated Clincal Research LLC West Palm Beach Florida 33406
Columbus Regional Research Institute Columbus Georgia 31904
Advanced Medical Research Sandy Springs Georgia 30328
Meridian Clinical Research, LLC Savannah Georgia 31406
Dawes Fretzin Clinical Research Group Indianapolis Indiana 46256
Randall Dermatology & Cosmetic Surgery West Lafayette Indiana 47906
Meridian Clinical Research, LLC Baton Rouge Louisiana 70808
Clinical Trials of SWLA Lake Charles Louisiana 70605
Oakland Hills Dermatology Auburn Hills Michigan 48326
Revival Research Institute, LLC Troy Michigan 48084
Washington University in St. Louis St Louis Missouri 63130
Icahn School of Medicine at Mount Sinai New York New York 10029
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
ClinOhio Research Services Columbus Ohio 43213
Clinical Research Solutions, LLC Milan Tennessee 38358
Progressive Clinical Research San Antonio Texas 78213
Dominion Medical Associates, Inc. Richmond Virginia 23233

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04019041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2023 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04019041 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →